Humacyte, Inc.Humacyte, Inc.Humacyte, Inc.

Humacyte, Inc.

No trades
No trades

Fundamentals and stats

Operating, investing, and financing activities

Free cash flow for Q2 26 is ‪−22.16 M‬ USD. For 2025, it was ‪−105.93 M‬ USD and operating cash flow was ‪−105.04 M‬ USD.

2020
2021
2022
2023
2024
2025
Cash flow from operating activities
Cash flow from investing activities
Cash flow from financing activities
MetricsCurrency: USD
2020
2021
2022
2023
2024
2025
TTM